Showing results (41-50 of 73) with videos related to
Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2011
Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentrationEyal Arbely, Eviatar Natan, Tobias Brandt, et al.European Journal of Medicinal Chemistry|April 28, 2018
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell linesMatthias G J Baud, Matthias R Bauer, Lorena Verduci, et al.ACS Pharmacology & Translational Science|November 21, 2022
Discovery of Nanomolar-Affinity Pharmacological Chaperones Stabilizing the Oncogenic p53 Mutant Y220CJoseph R Stephenson Clarke, Leon R Douglas, Patrick J Duriez, et al.Proceedings of the National Academy of Sciences of the United States of America|November 9, 2016
Design of a molecular support for cryo-EM structure determinationThomas G Martin, Tanmay A M Bharat, Andreas C Joerger, et al.Journal of Medicinal Chemistry|November 20, 2020
Pan-SMARCA/PB1 Bromodomain Inhibitors and Their Role in Regulating AdipogenesisMarek Wanior, Franziska Preuss, Xiaomin Ni, et al.Structure (London, England : 1993)|December 5, 2015
Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53Andreas C Joerger, Matthias R Bauer, Rainer Wilcken, et al.Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2Simon M Vogel, Matthias R Bauer, Andreas C Joerger, et al.Cell Death & Disease|March 1, 2026
Evaluation of non-canonical p53 functions in DNA replication and recombination for variant classificationRebecca Jansche, Benedikt Heitmeir, Ulrike Faust, et al.Journal of Medicinal Chemistry|December 29, 2022
Development of a Potent Cyclic Peptide Inhibitor of the nNOS/PSD-95 InteractionJavier R Balboa, Dominik J Essig, Sana Ma, et al.Future Medicinal Chemistry|October 22, 2019
A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220CMatthias R Bauer, Rhiannon N Jones, Raysa K Tareque, et al.Pageof 8